Cited 0 times in Scipus Cited Count

The Efficacy of Sclerotherapy for Conservative Treatment of Ovarian Pseudocyst

Other Title
난소의 가성 낭종의 보존적 치료로서 경화술의 효용성
Authors
안, 성희 | 유, 승철 | 조, 미영 | 김, 미란 | 황, 경주 | 유, 희석
Citation
Korean journal of fertility and sterility, 29(4). : 245-250, 2002
Journal Title
Korean journal of fertility and sterility
ISSN
1226-2951
Abstract
Objective: To evaluate the efficacy of sclerotherapy for conservative treatment of ovarian pseudocyst. Methods: Patients with ovarian pseudocyst who had undergone sclerotherapy at Ajou University Hospital from February, 1997 to March, 2002 were included in this study. Sclerotherapy was performed as follows: Under intravenous analgesia, the cyst was irrigated with dehydrated alcohol after aspiration under transvaginal sonography. The aspirated contents and alcohol irrigated contents were sent for cytologic examination. Results: 71 patients with ovarian pseudocyst were performed sclerotherapy. All but 2 patients were followed up for 0.5 to 33 months with transvaginal sonography and pelvic examination. Mean age of the patients was 40 years old. Mean size of the pseudocyst was 8.0 cm, mean amount of aspiration fluid was 179.8 ml, and average follow-up duration was 6.0 months. All had abdominal or pelvic surgical history and 38 patients (58.9%) of them had undergone hysterectomy. 44 of 71 patients (62.0%) were performed sclerotherapy only one time. 27 patients (38.0%) recurred and were undergone more than one time. Complication was not occurred in all cases. Conclusions: We concluded that although pseudocyst after sclerotherapy has high recurrence rate, sclerotherapy was an safe and effective method for conservative treatment of ovarian pseudocyst.
Keywords

Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Unclassified
Full Text Link
Files in This Item:
Korean Journal of the Fertility and Sterility_29(4)_245-250.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse